Hitoshi Ishizuka

1.7k total citations
56 papers, 1.4k citations indexed

About

Hitoshi Ishizuka is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hitoshi Ishizuka has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hitoshi Ishizuka's work include Drug Transport and Resistance Mechanisms (12 papers), Influenza Virus Research Studies (9 papers) and Hormonal Regulation and Hypertension (9 papers). Hitoshi Ishizuka is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Influenza Virus Research Studies (9 papers) and Hormonal Regulation and Hypertension (9 papers). Hitoshi Ishizuka collaborates with scholars based in Japan, Germany and United States. Hitoshi Ishizuka's co-authors include Toshihisa Ishikawa, C. David Wright, Kaoru Toyama, Hiromi Okabe, Erin G. Schuetz, Kazuto Yasuda, Jaideep V. Thottassery, Cynthia Brimer, Evan D. Kharasch and Tauri Senn and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and International Journal of Molecular Sciences.

In The Last Decade

Hitoshi Ishizuka

55 papers receiving 1.4k citations

Peers

Hitoshi Ishizuka
Rajgopal Govindarajan United States
Nghia Nguyen United States
Marie V. St–Pierre Switzerland
Leslie J. Dickmann United States
Jian Qu China
Markus Keiser Germany
Russell Gotschall United States
Colin Brown United Kingdom
Mayumi Saeki Japan
Maren Mieth Germany
Rajgopal Govindarajan United States
Hitoshi Ishizuka
Citations per year, relative to Hitoshi Ishizuka Hitoshi Ishizuka (= 1×) peers Rajgopal Govindarajan

Countries citing papers authored by Hitoshi Ishizuka

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Ishizuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Ishizuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Ishizuka more than expected).

Fields of papers citing papers by Hitoshi Ishizuka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Ishizuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Ishizuka. The network helps show where Hitoshi Ishizuka may publish in the future.

Co-authorship network of co-authors of Hitoshi Ishizuka

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Ishizuka. A scholar is included among the top collaborators of Hitoshi Ishizuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Ishizuka. Hitoshi Ishizuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tachibana, Masaya, et al.. (2023). Safety, Tolerability, and Pharmacokinetics of Valemetostat Tablets and the Effect of Food on Valemetostat Pharmacokinetics in Healthy Subjects: Two Phase 1 Studies. Clinical Pharmacology in Drug Development. 13(1). 77–86. 12 indexed citations
2.
Toyama, Kaoru, et al.. (2023). Pharmacokinetics and Bioequivalence of Mirogabalin Orally Disintegrating Tablets and Conventional Tablets in Healthy Japanese Participants. Clinical Pharmacology in Drug Development. 12(10). 985–990. 1 indexed citations
3.
Li, Yi, Kaoru Toyama, Hitoshi Ishizuka, et al.. (2023). Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study. Advances in Therapy. 40(4). 1628–1643. 4 indexed citations
4.
Toyama, Kaoru, Takashi Eto, Kenji Takazawa, et al.. (2023). DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2: Results from a phase 2 clinical study. Vaccine. 41(38). 5525–5534. 9 indexed citations
5.
Shiosakai, Kazuhito, Tatsuya Hashimoto, Takaaki Akasaka, et al.. (2022). Steady-State Pharmacokinetics of Intravenous Hydromorphone in Japanese Patients With Renal Impairment and Cancer Pain. Journal of Palliative Medicine. 26(6). 768–775. 2 indexed citations
6.
Toyama, Kaoru, Hidetoshi Furuie, Tomoko Ishizuka, et al.. (2021). Effects of Repeated Oral Administration of Esaxerenone on the Pharmacokinetics of Midazolam in Healthy Japanese Males. European Journal of Drug Metabolism and Pharmacokinetics. 46(5). 685–694. 2 indexed citations
7.
Shiramoto, Masanari, Tomoko Ishizuka, Shin Irie, et al.. (2020). Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects. BMC Pharmacology and Toxicology. 21(1). 55–55. 8 indexed citations
8.
Furuie, Hidetoshi, Emi Kamiyama, Akiko Watanabe, et al.. (2019). Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects. Clinical Drug Investigation. 39(10). 967–978. 3 indexed citations
9.
10.
Kurata, Akifumi, Hidetoshi Furuie, Tomoko Ishizuka, et al.. (2019). Absolute Bioavailability of Esaxerenone and Food Effects on its Pharmacokinetics After a Single Oral Dose in Healthy Japanese Subjects: An Open-Label Crossover Study. Advances in Therapy. 36(7). 1618–1627. 13 indexed citations
11.
12.
Ishizuka, Hitoshi, et al.. (2013). Population Pharmacokinetics of Laninamivir and Its Prodrug Laninamivir Octanoate in Healthy Subjects and in Adult and Pediatric Patients with Influenza Virus Infection. Drug Metabolism and Pharmacokinetics. 28(5). 416–426. 5 indexed citations
13.
Tokuhiro, Shinya, Akira Shinagawa, Joseph R. Walker, et al.. (2012). Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure. Journal of Human Genetics. 57(8). 531–544. 6 indexed citations
14.
15.
Tajima, Naoyuki, Hitoshi Ishizuka, & Hideo Naganuma. (2006). Population Pharmacokinetic Analysis of Panipenem/Betamipron in Patients with Various Degrees of Renal Function. Chemotherapy. 52(5). 245–253. 3 indexed citations
16.
Abe, K., et al.. (2006). Stereoselective pharmacokinetics of oxybutynin andN-desethyloxybutyninin vitroandin vivo. Xenobiotica. 37(1). 59–73. 18 indexed citations
17.
Thummel, Kenneth E., Cynthia Brimer, Kazuto Yasuda, et al.. (2001). Transcriptional Control of Intestinal Cytochrome P-4503A by 1α,25-Dihydroxy Vitamin D3. Molecular Pharmacology. 60(6). 1399–1406. 267 indexed citations
18.
Yamamoto, Chika, Hitomi Takanaga, Hirotami Matsuo, et al.. (1999). Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier. Biopharmaceutics & Drug Disposition. 20(2). 85–90. 13 indexed citations
19.
Ishizuka, Hitoshi, Hideo Naganuma, Kenji Nishimura, et al.. (1998). Transport of Temocaprilat into Rat Hepatocytes: Role of Organic Anion Transporting Polypeptide. Journal of Pharmacology and Experimental Therapeutics. 287(1). 37–42. 59 indexed citations
20.
Tanabe, Mitsuo, et al.. (1993). Sites of Action of CS-722, a Newly Synthesized Centrally Acting Muscle Relaxant. The Japanese Journal of Pharmacology. 63(3). 385–390. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rajgopal Govindarajan Breakdown of academic impact, for papers by Nghia Nguyen Breakdown of academic impact, for papers by Marie V. St–Pierre Breakdown of academic impact, for papers by Leslie J. Dickmann Breakdown of academic impact, for papers by Jian Qu Breakdown of academic impact, for papers by Markus Keiser Breakdown of academic impact, for papers by Russell Gotschall Breakdown of academic impact, for papers by Colin Brown Breakdown of academic impact, for papers by Mayumi Saeki Breakdown of academic impact, for papers by Maren Mieth
Rankless by CCL
2026